Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.51
-0.08-5.03%
À la fermeture: -
$1.54
0.031.99%
Après les heures de négociation: 6:34 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Biomea Fusion Inc a un objectif de cours consensus de $27.58, basé sur les évaluations des 20 analystes. Le plus élevé est de $128 attribué par EF Hutton le octobre 31, 2024, et le plus bas est de $3 attribué par Barclays le avril 2, 2025. Les 3 dernières évaluations d'analystes ont été publiées par D. Boral Capital, D. Boral Capital et Jefferies le octobre 7, 2025, octobre 3, 2025 et août 28, 2025. Avec un objectif de cours moyen de $12.33 entre D. Boral Capital, D. Boral Capital et Jefferies, il y a une variation implicite de 700.87% upside pour Biomea Fusion Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
D. Boral Capital
Jefferies
Citigroup
Scotiabank
Piper Sandler
1calculé à partir des notes des analystes
Notes d'analystes pour Biomea Fusion
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/07/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
10/03/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
08/28/2025 | 224.68% | Jefferies | → $5 | Initiates | → Buy | |||
08/11/2025 | 354.55% | Citigroup | $9 → $7 | Maintains | Buy | |||
08/06/2025 | 549.35% | Scotiabank | $30 → $10 | Maintains | Sector Outperform | |||
08/06/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
07/21/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
07/16/2025 | 484.42% | Citigroup | $22 → $9 | Maintains | Buy | |||
06/24/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
06/18/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
06/13/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
06/03/2025 | 354.55% | Piper Sandler | → $7 | Assumes | → Overweight | |||
05/15/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
05/06/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
05/06/2025 | 1068.83% | HC Wainwright & Co. | $40 → $18 | Maintains | Buy | |||
04/02/2025 | 94.81% | Barclays | $11 → $3 | Maintains | Equal-Weight | |||
04/01/2025 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
03/31/2025 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
03/25/2025 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
03/24/2025 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
03/24/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
03/19/2025 | 938.96% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
01/16/2025 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
01/14/2025 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
01/13/2025 | 938.96% | D. Boral Capital | $128 → $16 | Maintains | Buy | |||
01/10/2025 | 8211.69% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
12/19/2024 | 8211.69% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
12/18/2024 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
12/17/2024 | 8211.69% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
12/16/2024 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
12/10/2024 | 8211.69% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
12/10/2024 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
11/21/2024 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
11/19/2024 | 8211.69% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
10/31/2024 | 1133.77% | Piper Sandler | $10 → $19 | Maintains | Overweight | |||
10/31/2024 | 8211.69% | EF Hutton | $128 → $128 | Maintains | Buy | |||
10/31/2024 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
10/30/2024 | 614.29% | Barclays | $9 → $11 | Maintains | Equal-Weight | |||
10/30/2024 | 8211.69% | EF Hutton | $128 → $128 | Maintains | Buy | |||
10/22/2024 | 2497.4% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
10/09/2024 | 8211.69% | EF Hutton | → $128 | Initiates | → Buy | |||
09/27/2024 | 2562.34% | Scotiabank | $21 → $41 | Maintains | Sector Outperform | |||
09/27/2024 | 2497.4% | HC Wainwright & Co. | $15 → $40 | Maintains | Buy | |||
09/27/2024 | 484.42% | Barclays | $5 → $9 | Maintains | Equal-Weight | |||
09/27/2024 | 3406.49% | Truist Securities | $54 → $54 | Upgrade | Hold → Buy | |||
09/26/2024 | 1068.83% | Rodman & Renshaw | → $18 | Upgrade | Neutral → Buy | |||
08/29/2024 | 1523.38% | Capital One | → $25 | Initiates | → Overweight | |||
08/27/2024 | 1328.57% | Citigroup | $45 → $22 | Maintains | Buy | |||
08/01/2024 | 874.03% | HC Wainwright & Co. | $15 → $15 | Reiterates | Buy → Buy | |||
06/25/2024 | 874.03% | HC Wainwright & Co. | $15 → $15 | Reiterates | Buy → Buy | |||
06/11/2024 | — | Truist Securities | — | Downgrade | Buy → Hold | |||
06/07/2024 | 2822.08% | Citigroup | $90 → $45 | Maintains | Buy | |||
06/07/2024 | 874.03% | HC Wainwright & Co. | $50 → $15 | Maintains | Buy | |||
06/07/2024 | 549.35% | Piper Sandler | $45 → $10 | Maintains | Overweight | |||
06/07/2024 | 224.68% | Barclays | $30 → $5 | Downgrade | Overweight → Equal-Weight | |||
06/07/2024 | 1263.64% | Scotiabank | $41 → $21 | Maintains | Sector Outperform | |||
05/30/2024 | 3796.1% | Oppenheimer | $70 → $60 | Maintains | Outperform | |||
05/03/2024 | 3146.75% | HC Wainwright & Co. | $50 → $50 | Reiterates | Buy → Buy | |||
05/03/2024 | 874.03% | JP Morgan | $14 → $15 | Maintains | Neutral | |||
04/03/2024 | 4445.45% | Oppenheimer | → $70 | Maintains | Outperform | |||
04/02/2024 | 809.09% | JP Morgan | $51 → $14 | Downgrade | Overweight → Neutral | |||
04/01/2024 | 3146.75% | HC Wainwright & Co. | $50 → $50 | Reiterates | Buy → Buy | |||
04/01/2024 | 3471.43% | Truist Securities | → $55 | Reiterates | Buy → Buy | |||
03/06/2024 | 3146.75% | HC Wainwright & Co. | $50 → $50 | Reiterates | Buy → Buy | |||
02/06/2024 | 3471.43% | Truist Securities | → $55 | Initiates | → Buy | |||
12/08/2023 | 5744.16% | Citigroup | → $90 | Reiterates | Buy → Buy | |||
08/01/2023 | 2692.21% | EF Hutton | → $43 | Reiterates | Buy → Buy | |||
08/01/2023 | 3146.75% | HC Wainwright & Co. | → $50 | Reiterates | Buy → Buy | |||
07/27/2023 | 2562.34% | Scotiabank | → $41 | Initiates | → Sector Outperform | |||
07/25/2023 | 2692.21% | EF Hutton | → $43 | Reiterates | Buy → Buy | |||
07/24/2023 | 3146.75% | HC Wainwright & Co. | $50 → $50 | Reiterates | Buy → Buy | |||
07/12/2023 | 2692.21% | EF Hutton | → $43 | Reiterates | Buy → Buy | |||
06/26/2023 | 1718.18% | Jefferies | $36 → $28 | Downgrade | Buy → Hold | |||
06/26/2023 | 2822.08% | Piper Sandler | $40 → $45 | Maintains | Overweight | |||
06/26/2023 | 3211.69% | JP Morgan | $38 → $51 | Maintains | Overweight | |||
06/26/2023 | 5744.16% | Citigroup | $53 → $90 | Maintains | Buy | |||
06/26/2023 | 1977.92% | EF Hutton | → $32 | Reiterates | Buy → Buy | |||
06/26/2023 | 3146.75% | HC Wainwright & Co. | $37 → $50 | Maintains | Buy | |||
05/25/2023 | 1977.92% | EF Hutton | → $32 | Assumes | → Buy | |||
05/18/2023 | 3341.56% | Citigroup | $55 → $53 | Maintains | Buy | |||
05/12/2023 | 3146.75% | Barclays | → $50 | Initiates | → Overweight | |||
05/04/2023 | 1977.92% | EF Hutton | $33 → $32 | Reiterates | → Buy | |||
05/03/2023 | 2302.6% | HC Wainwright & Co. | → $37 | Reiterates | → Buy | |||
04/19/2023 | 2302.6% | HC Wainwright & Co. | $44 → $37 | Maintains | Buy | |||
04/11/2023 | 2951.95% | Oppenheimer | → $47 | Reiterates | → Outperform | |||
04/07/2023 | 3471.43% | Citigroup | $60 → $55 | Maintains | Buy | |||
04/06/2023 | 2042.86% | EF Hutton | → $33 | Reiterates | → Buy | |||
03/29/2023 | 2951.95% | Oppenheimer | $25 → $47 | Maintains | Outperform | |||
03/29/2023 | 3796.1% | Citigroup | $20 → $60 | Maintains | Buy | |||
03/29/2023 | 2757.14% | HC Wainwright & Co. | → $44 | Reiterates | → Buy | |||
03/28/2023 | 2757.14% | HC Wainwright & Co. | $37 → $44 | Reiterates | → Buy | |||
03/28/2023 | 2042.86% | EF Hutton | $22 → $33 | Maintains | Buy | |||
03/28/2023 | 2497.4% | Piper Sandler | $16 → $40 | Maintains | Overweight | |||
03/24/2023 | 1328.57% | Keefe, Bruyette & Woods | → $22 | Reiterates | → Buy | |||
03/22/2023 | 1328.57% | EF Hutton | → $22 | Reiterates | → Buy | |||
03/21/2023 | 1328.57% | EF Hutton | → $22 | Reiterates | → Buy | |||
02/24/2023 | 1198.7% | Citigroup | → $20 | Initiates | → Buy | |||
01/13/2023 | 2302.6% | HC Wainwright & Co. | → $37 | Reiterates | → Buy | |||
11/08/2022 | 1328.57% | EF Hutton | $27 → $22 | Maintains | Buy | |||
11/01/2022 | 1653.25% | EF Hutton | → $27 | Initiates | → Buy |
FAQ
Quel est le cours indicatif de l'action Biomea Fusion (BMEA) ?
Le dernier objectif de prix pour Biomea Fusion (NASDAQ:BMEA) a été rapporté par D. Boral Capital le octobre 7, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $16.00 s'attendant à ce que BMEA se rise dans les 12 prochains mois (un possible changement de 938.96% upside). 40 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Biomea Fusion (BMEA) ?
La dernière note d'analyste pour Biomea Fusion (NASDAQ:BMEA) a été fournie par D. Boral Capital, et Biomea Fusion maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour Biomea Fusion (BMEA) ?
La dernière amélioration pour Biomea Fusion Inc a eu lieu le septembre 27, 2024 lorsque Truist Securities a augmenté leur objectif de prix à $54. Truist Securities avait précédemment a hold pour Biomea Fusion Inc.
Quand a eu lieu la dernière dégradation pour Biomea Fusion (BMEA) ?
La dernière réduction pour Biomea Fusion Inc a eu lieu le juin 11, 2024 lorsque Truist Securities a changé leur objectif de prix de N/A à N/A pour Biomea Fusion Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Biomea Fusion (BMEA) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Biomea Fusion, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Biomea Fusion a été déposée le octobre 7, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 7, 2026.
La note d'analyste pour Biomea Fusion (BMEA) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Biomea Fusion (BMEA) était un maintenu avec un objectif de prix de $16.00 à $16.00. Le prix actuel de Biomea Fusion (BMEA) est de $1.54, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.